1st PARKINSON Symposium – Exhibition – ENCOUNTER NDGD

AiMedicine » Symposiums » 1st PARKINSON Symposium – Exhibition – ENCOUNTER NDGD

REPLY CONTACT FORM

Enter personal data

Your Email

Your Company Name

Your Country

Choose the role you want to play

Wish to be lecturerWish to be exhibitorWish to be sponsorWish to exhibit a film at the MEDICAL FILM FESTIVALWish to appear at the INTELLIGENT ROBOTS WHO IS WHO DIRECTORY 26wish to be member at the INTELLIGENT ROBOTS scientific committee boardCall for technology transferCall for searching partnersCall for business opportunities

Others

Do you have a comment?*

Do you have a project?

Summary presentation

Profile

Title page*

Full Title*

Author name*

Professiona degree*

Adress*

Email*

Wesite*

Phone*

Keywords*

Subject*

Title*

Author (s)*

Text presentation*

Grants

Reference - Works & Publications

Summary of maximum four pages (in native language and in English, French ).
Attach files

TOPICS

Neurodegenerative diseases NDGD: Alzheimer Encounter

Neurodegenerative diseases NDGD:

Alzheimer Encounter

The High-Tech effects -challenges on Alzheimer NDGD
Research on Alzheimer NDGD
How to innovate on Alzheimer
The state of art and future on Alzheimer NDGD
The Actors companies on Alzheimer NDGD
The Market on Alzheimer NDGD
Neurosurgery
Neuroscience
Etiology, pathogenesis
Minimal cognitive impairment
Lewy body dementia
Front-temporal dementia
Brain disorders : Schizophrenia…
Depression & psychotic states
Cognitive impairments in auto-immune disorders
Amyotrophic lateral sclerosis

Multiple systems atrophy
Genetics
Neurogenetics
Epidemiology
Biomarkers
Diagnostics
Neuroimaging
Pharmacy-economics, quality of life
Treatment
Drug interaction
Cholinergic treatment
Glutamatergic treatment
Cholesterol and lipids in β role
Stems cells transplantation
Drugs delivery by nanotechnologies
Drug for patients suffering from cognitive deficits
Drug for effective treatment against the debilitative Alzheimer’s disease.

Paint Treatment

CANCER

Paint Treatment

The High-Tech effects -challenges on Oncolgy MFD
Research on Oncolgy MFD
How to innovate on Oncolgy MFD
The state of art and future on Oncolgy MFD
The Actors companies on Oncolgy MFD
The Market on Oncology MFD
Multifactorial Disease MFD:
Neurogenesis
Neuroimaging
Epidemiology
Breast
Colon rectal
Hematologic
Genital
Gynecologic
Melanoma
Ovarian
Metastatic Tumours Facilitated by Hypoxic Tumour Micro-Environments

Molecular biotechnology
Molecular imaging
Molecular radioisotopes development
Medical radioisotopes
Biothermodynamics and Drug design anticancer Target
Implantable Intrathecal technologies
Pain Treatment Therapy MFD
Pain treatment technologies
Stems cells transplantation∙ Genetics
Pharmacy-economics, quality of life
Treatment
Drug interaction
Drugs delivery by nanotechnologies
Surgery interventions-demonstrations live and Online assisted by Hi-Tech
Therapy using radionuclides

Call for Papers

MEDSANF Sans Frontières® and the Artificial Intelligence French Association AFIAS® invite Authors, Lecturers, Speakers, propose PAPERS to the Scientific Committee of the Artificial Intelligence in Medicine AI in MEDICINE 26 Summit.

Scientific Topics

Digital Revolution on Medicine ∙ Medical Robotics ∙ Nuclear Medicine ∙ Nano Medicine ∙ Nano Bio ∙ Nano Sciences ∙ Nanotechnologies ∙ Artificial Intelligence in Medicine ∙ Cancer – Pain Treatment ∙ Alzheimer Encounter SYMPOSIUM ∙ AUTISME SYMPOSIUM ∙ DOWN SYNDROME SYMPOSIUM ∙ Parkinson Encounter ∙ Tomorrow’s Hospital Architecture-Engineering Design ∙ Hospital assisted by High-Tech ∙ Medical Science Technology Film ∙ The human factor confronted to Digital Revolution: a brake or an opportunity? ∙ University Enterprise Interaction-Cooperation in medicine assisted by high tech ∙ OTHER
MEDSANF Sans Frontières® and the Artificial Intelligence French Association AFIAS® invite authors suggest PAPERS to the Scientific Committee of the Artificial Intelligence in Medicine AI in MEDICINE.

Profile of :Authors , Lecturers y Speakers

∙Researchers ∙ investigators ∙Lecturers ∙Trainers ∙Maintenance Engineers ∙Technicians ∙Experts ∙ Consultants ∙ MD ∙ Nuclear engineers ∙ Physicals engineers ∙Robotics engineers ∙ Artificial Intelligence engineers Nano sciences engineers ∙ Nanotechnologies engineers ∙ Managers ∙ Chairman, ∙ CEO ∙ Presidents ∙ Directors of industrial and corporate organizations.

Instructions to: Authors, Lecturers y Speakers

The authors in order to present results of their research and / or technological innovations as products, processes or methodologies
The authors can to submitting work on case studies and / or outputs (products, processes and methodologies) concrete created, developed and / or implemented in their respective companies and / or its organizations.

Authorization – Permission

Authors are responsible for obtaining written permission for all non-original or pre-published material. Please clearly identify any material originating from another source, and include written permission for reprinting from the original copyright holder (usually the publisher). Copies of letters to the copyright holder requesting permission will be accepted in the submission package, pending successful follow up. Please note that information originating by Governments is considered public domain and does not require permission for re-use.

Copyright

By the simple act of participating Authors, Lecturers, Speakers granted all copyrights to MEDSANF Sans Frontières.org® in order that the papers are published in the form: paper, film, internet, digital system, video, audio, CD-DVD.

The MEDSANF Sans Frontières® (1) The international events presented as the Conferences, the surgery interventions live and online, as the Exhibitions will be filmed and comprehensive records and / or part will be published in digital form, internet, and paper, audio.
The Conferences, the Exhibitions will be filmed and comprehensive records and / or part will be published in digital form, internet, and paper, audio.

If your proposal is accepted, send the full article before the date indicated, complying with the requirements and recommendations listed by the Scientific Committee, if any.

By the simple act of participating Authors, Lecturers, Speakers granted all copyrights to MEDSANF Sans Frontières® in order that the papers are published in the form: paper, film, internet, digital system, video, audio, CD-DVD.

Comments, Questions or additional information you think would be useful communicate to the organizers MEDSANF Sans Frontières® and the Artificial Intelligence French Association AFIAS®:

If you require further information please write to email address:
president@medsanfsansfrontieres.org

Thank you for the valuable time dedicated to complete this Call for PAPERS application form as Author,Lecturer-Speaker

Copyright » : Tout reproduction, même partielle, des textes et documents du présent Web est soumise à l’autorisation préalable de son Concepteur, Producteur – Editeur Monsieur Edouard VALDES-SAZO ( Articles L.111-1, L.122-4 CPI &L.335-2 CPI ) du Code Pénal de la République Français.